abstract |
The present invention relates to novel phenyl derivatives, and these products show good affinity for certain subtypes of cannabinoid receptors, in particular the CB2 receptor. They are of particular interest for the treatment of pathological conditions and diseases involving at least one cannabinoid receptor. The invention also relates to a pharmaceutical composition comprising the product and its use for the manufacture of a drug. |